Year: 2022

Group-brand-mark_H-Type_rgb_full-color

Shionogi Presents Real-World Evidence Showing Strong Efficacy with Fetroja® (cefiderocol) Against Treatment Resistant Bacterial Infections at IDWeek 2022

Real-world evidence demonstrated that Fetroja achieved clinical cure in 63% of patients with Acinetobacter baumannii infections (48/76) or Pseudomonas aeruginosa...

gg_1-3

Genius Group Ltd. Announces 17.18% Revenue Growth in First Half of 2022 and Expansion of Gross Margin on a Pro Forma Basis to 48.49%

SINGAPORE--(BUSINESS WIRE)--$GNS #GNS--Genius Group Limited (“Genius Group” or the “Company”) (NYSE American: GNS), a leading entrepreneur Edtech and education group,...